by Anthony Czelusniak, Vanderbilt University James Crowe, Jr., MD, left, and Naveenchandra Suryadevara, PhD, have discovered a monoclonal antibody with therapeutic potential that neutralizes both RSV and hMPV. Credit: Vanderbilt University Vanderbilt University Medical Center and Stanford University researchers discovered a potent, cross-neutralizing human monoclonal antibody against the respiratory syncytial virus (RSV) and human metapneumovirus (hMPV). The findings,...
